Luna Innovations Reports Strong Third-Quarter 2022 Results
Luna Innovations reported Q3 2022 revenues of $29.2 million, marking a 43% increase year-over-year, with a 58% gross margin. Net income rose to $1.2 million, up from $0.4 million a year earlier, while Adjusted EBITDA surged to $4.5 million, up 115%. For the nine months, revenues were $77.8 million, a 23% increase. The company reaffirmed full-year 2022 guidance of $109 million to $115 million in revenue and $10 million to $12 million in Adjusted EBITDA, highlighting continued growth despite supply chain challenges.
- Total Q3 revenues increased 43% to $29.2 million year-over-year.
- Net income in Q3 improved to $1.2 million from $0.4 million the previous year.
- Adjusted EBITDA for Q3 reached $4.5 million, up 115% year-over-year.
- Revenues for nine months increased 23% to $77.8 million.
- Gross margin decreased to 58% from 62% in the previous year, attributed to product mix.
- Operating expenses increased 23% year-over-year, impacting profitability.
Reaffirms Outlook
Q3 Highlights
-
Total revenues of
, up$29.2 million 43% year-over-year -
Total revenues in constant currency of
; up$30.1 million 48% year-over-year -
Gross margin of
58% , compared to62% for the prior-year period -
Net income of
, compared to net income of$1.2 million for the prior-year period$0.4 million -
Adjusted EBITDA of
, compared to$4.5 million for the prior-year period$2.1 million -
Adjusted EPS of
, compared to$0.09 for the prior-year period$0.03
"I'm extremely pleased with our performance in Q3, achieving over
Graeff continued, “With three quarters now behind us, we feel very comfortable that we will finish 2022 within the ranges that we provided on our March earnings call. As always, we remain focused on execution, both to capitalize on important growth trends and to advance our strategy of Enabling the Future with Fiber.”
Third-Quarter Fiscal 2022 Financial Summary
Highlights of the financial results for the three months ended
|
|
Three Months Ended |
|
Change |
|||||||
(in thousands, except share and per share data) |
|
|
2022 |
|
|
|
2021 |
|
|
|
|
Revenues |
|
$ |
29,153 |
|
|
$ |
20,329 |
|
|
43 |
% |
|
|
|
|
|
|
|
|||||
Gross profit |
|
|
16,919 |
|
|
|
12,584 |
|
|
34 |
% |
Gross margin |
|
|
58 |
% |
|
|
62 |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating expense |
|
|
15,441 |
|
|
|
12,594 |
|
|
23 |
% |
Operating income/(loss) |
|
|
1,478 |
|
|
|
(10 |
) |
|
|
|
Operating margin |
|
|
5 |
% |
|
|
— |
% |
|
|
|
|
|
|
|
|
|
||||||
Other expense, net and income tax expense |
|
|
(310 |
) |
|
|
(334 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Net income/(loss) from continuing operations |
|
$ |
1,168 |
|
|
$ |
(344 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Income from discontinued operations, net of income taxes |
|
|
28 |
|
|
|
699 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
1,196 |
|
|
$ |
355 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income per diluted share (EPS) |
|
$ |
0.04 |
|
|
$ |
0.01 |
|
|
|
|
Adjusted EPS |
|
$ |
0.09 |
|
|
$ |
0.03 |
|
|
200 |
% |
Diluted weighted average shares outstanding |
|
|
34,104,850 |
|
|
|
33,780,714 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA |
|
$ |
4,544 |
|
|
$ |
2,110 |
|
|
115 |
% |
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable figures under generally accepted accounting principles ("GAAP") can be found in the schedules included in this release.
Revenues for the three months ended
Gross margin was
Net income was
Adjusted EBITDA was
Nine Months Ended Fiscal 2022 Financial Summary
Highlights of the financial results for the nine months ended
|
|
Nine Months Ended |
|
Change |
|||||||
(in thousands, except share and per share data) |
|
|
2022 |
|
|
|
2021 |
|
|
|
|
Revenues |
|
|
77,795 |
|
|
|
63,291 |
|
|
23 |
% |
|
|
|
|
|
|
|
|||||
Gross profit |
|
|
47,162 |
|
|
|
37,436 |
|
|
26 |
% |
Gross margin |
|
|
61 |
% |
|
|
59 |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating expense |
|
|
50,510 |
|
|
|
41,061 |
|
|
23 |
% |
Operating loss |
|
|
(3,348 |
) |
|
|
(3,625 |
) |
|
|
|
Operating margin |
|
|
(4 |
)% |
|
|
(6 |
)% |
|
|
|
|
|
|
|
|
|
||||||
Other expense, net and income tax benefit |
|
|
231 |
|
|
|
1,061 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net loss from continuing operations |
|
$ |
(3,117 |
) |
|
$ |
(2,564 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Income from discontinued operations, net of income taxes |
|
|
11,543 |
|
|
|
2,371 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income/(loss) |
|
$ |
8,426 |
|
|
$ |
(193 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings/(loss) per diluted share (EPS) |
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
|
|
|
Adjusted EPS |
|
$ |
0.12 |
|
|
$ |
0.08 |
|
|
50 |
% |
Diluted weighted average shares outstanding |
|
|
32,492,276 |
|
|
|
33,585,973 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA |
|
$ |
7,450 |
|
|
$ |
4,461 |
|
|
67 |
% |
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable GAAP figures can be found in the schedules included in this release.
Revenues for the nine months ended
Gross profit of
Net income was
Adjusted EBITDA was
2022 Full-Year Outlook
Luna is reaffirming the 2022 revenue and adjusted EBITDA outlook it originally provided on
-
Total revenue of
to$109 million for the full year 2022$115 million -
Adjusted EBITDA of
to$10 million for the full year 2022$12 million
Luna is not providing an outlook for net income, which is the most directly comparable GAAP measure to Adjusted EBITDA, because changes in the items that Luna excludes from net income to calculate Adjusted EBITDA, such as share-based compensation, tax expense, and significant non-recurring charges, among other things, can be dependent on future events that are less capable of being controlled or reliably predicted by management and are not part of Luna's routine operating activities.
The outlook above does not include any future acquisitions, divestitures, or unanticipated events.
Non-GAAP Financial Measures
In evaluating the operating performance of its business, Luna’s management considers Adjusted EBITDA, Adjusted EPS and revenue measured on a constant currency basis, which are non-GAAP financial measures. Adjusted EBITDA and Adjusted EPS exclude certain charges and income that are required by GAAP. Adjusted EBITDA and Adjusted EPS provide useful information to both management and investors by excluding the effect of certain non-cash expenses and items that Luna believes may not be indicative of its operating performance, because either they are unusual and Luna does not expect them to recur in the ordinary course of its business, or they are unrelated to the ongoing operation of the business in the ordinary course.
The Company calculates revenue measured on a constant currency basis by translating its foreign revenues for the relevant period in
Adjusted EBITDA, Adjusted EPS and revenue measured on a constant currency basis should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. Adjusted EBITDA and Adjusted EPS have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at
About Luna
Forward-Looking Statements
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include Luna's expectations regarding its projected full year 2022 financial results and outlook, and the Company's ability to capitalize on growth trends. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of Luna may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for Luna's products and services to meet expectations, failure of target market to grow and expand, technological and strategic challenges, uncertainties related to the ultimate impact of the COVID-19 pandemic and those risks and uncertainties set forth in Luna’s Form 10-Q for the quarter ended
Consolidated Balance Sheets (Unaudited) (in thousands, except share data) |
|||||||
|
|
|
|
||||
|
(unaudited) |
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
7,889 |
|
|
$ |
17,128 |
|
Accounts receivable, net |
|
29,295 |
|
|
|
20,913 |
|
Contract assets |
|
6,196 |
|
|
|
5,166 |
|
Inventory |
|
32,400 |
|
|
|
22,493 |
|
Prepaid expenses and other current assets |
|
4,744 |
|
|
|
3,793 |
|
Assets held for sale |
|
— |
|
|
|
12,952 |
|
Total current assets |
|
80,524 |
|
|
|
82,445 |
|
Property and equipment, net |
|
4,827 |
|
|
|
2,988 |
|
Intangible assets, net |
|
18,964 |
|
|
|
17,177 |
|
|
|
27,215 |
|
|
|
18,984 |
|
Operating lease right-of-use assets |
|
4,069 |
|
|
|
5,075 |
|
Other non-current assets |
|
3,251 |
|
|
|
247 |
|
Deferred tax asset |
|
6,397 |
|
|
|
3,321 |
|
Total assets |
$ |
145,247 |
|
|
$ |
130,237 |
|
Liabilities and stockholders’ equity |
|
|
|
||||
Liabilities: |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Current portion of long-term debt obligations |
$ |
2,250 |
|
|
$ |
4,167 |
|
Accounts payable |
|
5,370 |
|
|
|
2,809 |
|
Accrued and other current liabilities |
|
19,237 |
|
|
|
9,258 |
|
Contract liabilities |
|
4,850 |
|
|
|
4,649 |
|
Current portion of operating lease liabilities |
|
2,115 |
|
|
|
2,101 |
|
Liabilities associated with assets held for sale |
|
— |
|
|
|
9,703 |
|
Total current liabilities |
|
33,822 |
|
|
|
32,687 |
|
Long-term debt obligations, net of current portion |
|
19,465 |
|
|
|
11,673 |
|
Long-term portion of operating lease liabilities |
|
2,374 |
|
|
|
3,509 |
|
Deferred tax liability |
|
1,324 |
|
|
|
— |
|
Other long-term liabilities |
|
408 |
|
|
|
445 |
|
Total liabilities |
|
57,393 |
|
|
|
48,314 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock, par value |
|
35 |
|
|
|
34 |
|
|
|
(5,542 |
) |
|
|
(5,248 |
) |
Additional paid-in capital |
|
103,264 |
|
|
|
98,745 |
|
Accumulated deficit |
|
(3,149 |
) |
|
|
(11,575 |
) |
Accumulated other comprehensive loss |
|
(6,754 |
) |
|
|
(33 |
) |
Total stockholders’ equity |
|
87,854 |
|
|
|
81,923 |
|
Total liabilities and stockholders’ equity |
$ |
145,247 |
|
|
$ |
130,237 |
|
Consolidated Statements of Operations (Unaudited) (in thousands, except share and per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
||||||||||||
Revenues |
$ |
29,153 |
|
|
$ |
20,329 |
|
|
$ |
77,795 |
|
|
$ |
63,291 |
|
Cost of revenues |
|
12,234 |
|
|
|
7,745 |
|
|
|
30,633 |
|
|
|
25,855 |
|
Gross profit |
|
16,919 |
|
|
|
12,584 |
|
|
|
47,162 |
|
|
|
37,436 |
|
Operating expense: |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
12,665 |
|
|
|
9,674 |
|
|
|
42,527 |
|
|
|
33,414 |
|
Research, development and engineering |
|
2,776 |
|
|
|
2,920 |
|
|
|
7,983 |
|
|
|
7,647 |
|
Total operating expense |
|
15,441 |
|
|
|
12,594 |
|
|
|
50,510 |
|
|
|
41,061 |
|
Operating income/(loss) |
|
1,478 |
|
|
|
(10 |
) |
|
|
(3,348 |
) |
|
|
(3,625 |
) |
Other income/(expense): |
|
|
|
|
|
|
|
||||||||
Other income |
|
73 |
|
|
|
— |
|
|
|
146 |
|
|
|
— |
|
Interest expense, net |
|
(218 |
) |
|
|
(110 |
) |
|
|
(442 |
) |
|
|
(375 |
) |
Total other expense, net |
|
(145 |
) |
|
|
(110 |
) |
|
|
(296 |
) |
|
|
(375 |
) |
Income/(loss) from continuing operations before income taxes |
|
1,333 |
|
|
|
(120 |
) |
|
|
(3,644 |
) |
|
|
(4,000 |
) |
Income tax expense/(benefit) |
|
165 |
|
|
|
224 |
|
|
|
(527 |
) |
|
|
(1,436 |
) |
Net income/(loss) from continuing operations |
|
1,168 |
|
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Income from discontinued operations, net of income tax (benefit)/expense of ( |
|
28 |
|
|
|
699 |
|
|
|
622 |
|
|
|
2,371 |
|
Gain on sale of discontinued operations, net of tax of |
|
— |
|
|
|
— |
|
|
|
10,921 |
|
|
|
— |
|
Net income from discontinued operations |
|
28 |
|
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) |
$ |
1,196 |
|
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income/(loss) per share from continuing operations: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.04 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
Diluted |
$ |
0.03 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
Net income per share from discontinued operations: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
— |
|
|
$ |
0.02 |
|
|
$ |
0.36 |
|
|
$ |
0.08 |
|
Diluted |
$ |
— |
|
|
$ |
0.02 |
|
|
$ |
0.36 |
|
|
$ |
0.07 |
|
Net income/(loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
Diluted |
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
Weighted average shares: |
|
|
|
|
|
|
|
||||||||
Basic |
|
32,800,690 |
|
|
|
31,944,869 |
|
|
|
32,492,276 |
|
|
|
31,553,998 |
|
Diluted |
|
34,104,850 |
|
|
|
33,780,714 |
|
|
|
32,492,276 |
|
|
|
33,585,973 |
|
Consolidated Statements of Cash Flows (Unaudited) (in thousands) |
|||||||
|
Nine Months Ended |
||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
||||||
Cash flows (used in)/provided by operating activities |
|
|
|
||||
Net income/(loss) |
$ |
8,426 |
|
|
$ |
(193 |
) |
Adjustments to reconcile net income/(loss) to net cash used in operating activities |
|
|
|
||||
Depreciation and amortization |
|
3,993 |
|
|
|
3,523 |
|
Share-based compensation |
|
3,204 |
|
|
|
2,230 |
|
Gain from discontinued operations, net of tax |
|
(10,921 |
) |
|
|
— |
|
Deferred taxes |
|
(3,374 |
) |
|
|
(23 |
) |
Change in assets and liabilities |
|
|
|
||||
Accounts receivable |
|
(6,166 |
) |
|
|
482 |
|
Contract assets |
|
(2,739 |
) |
|
|
837 |
|
Inventory |
|
(6,662 |
) |
|
|
(1,906 |
) |
Other current assets |
|
2,093 |
|
|
|
(1,752 |
) |
Other long-term assets |
|
599 |
|
|
|
— |
|
Accounts payable and accrued and other current liabilities |
|
5,824 |
|
|
|
(1,681 |
) |
Contract liabilities |
|
2,425 |
|
|
|
(287 |
) |
Other long term-liabilities |
|
13 |
|
|
|
— |
|
Net cash (used in)/provided by operating activities |
|
(3,285 |
) |
|
|
1,230 |
|
Cash flows used in investing activities |
|
|
|
||||
Acquisition of property and equipment |
|
(2,313 |
) |
|
|
(943 |
) |
Intangible property costs |
|
4 |
|
|
|
(215 |
) |
Proceeds from sale of property and equipment |
|
25 |
|
|
|
— |
|
Proceeds from sale of discontinued operations |
|
12,973 |
|
|
|
— |
|
Acquisition of Lios |
|
(22,085 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(11,396 |
) |
|
|
(1,158 |
) |
Cash flows provided by/(used in) financing activities |
|
|
|
||||
Payments on finance lease obligations |
|
(36 |
) |
|
|
(36 |
) |
Proceeds from borrowings under debt obligations |
|
22,150 |
|
|
|
— |
|
Payments of debt obligations |
|
(16,275 |
) |
|
|
(3,110 |
) |
Repurchase of common stock |
|
(294 |
) |
|
|
(420 |
) |
Proceeds from ESPP |
|
521 |
|
|
|
530 |
|
Proceeds from the exercise of options |
|
1,160 |
|
|
|
2,076 |
|
Net cash provided by/(used in) financing activities |
|
7,226 |
|
|
|
(960 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(1,784 |
) |
|
|
277 |
|
Net decrease in cash and cash equivalents |
|
(9,239 |
) |
|
|
(611 |
) |
Cash and cash equivalents-beginning of period |
|
17,128 |
|
|
|
15,366 |
|
Cash and cash equivalents-end of period |
$ |
7,889 |
|
|
$ |
14,755 |
|
Reconciliation of Net Income/(Loss) to EBITDA and Adjusted EBITDA (in thousands) |
||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||
|
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
|||||||||||
Net income/(loss) |
$ |
1,196 |
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income from discontinued operations |
|
28 |
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) from continuing operations |
|
1,168 |
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Interest expense, net |
|
218 |
|
|
110 |
|
|
|
442 |
|
|
|
375 |
|
Income tax expense/(benefit) |
|
165 |
|
|
224 |
|
|
|
(527 |
) |
|
|
(1,436 |
) |
Depreciation and amortization |
|
1,299 |
|
|
1,131 |
|
|
|
3,993 |
|
|
|
3,440 |
|
EBITDA |
|
2,850 |
|
|
1,121 |
|
|
|
791 |
|
|
|
(185 |
) |
Share-based compensation |
|
1,027 |
|
|
689 |
|
|
|
3,027 |
|
|
|
2,133 |
|
Integration and transaction expense |
|
184 |
|
|
196 |
|
|
|
2,184 |
|
|
|
2,073 |
|
Amortization of inventory step-up |
|
134 |
|
|
104 |
|
|
|
391 |
|
|
|
440 |
|
Other non-recurring charges (1) |
|
349 |
|
|
— |
|
|
|
1,057 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
4,544 |
|
$ |
2,110 |
|
|
$ |
7,450 |
|
|
$ |
4,461 |
|
(1) - Other non-recurring charges include severance, customer accommodation, facility consolidation and debt refinancing costs. |
Reconciliation of Net Income/(Loss) to Adjusted EPS (in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
||||||||||||
Net income/(loss) |
$ |
1,196 |
|
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income from discontinued operations |
|
28 |
|
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) from continuing operations |
|
1,168 |
|
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Share-based compensation |
|
1,027 |
|
|
|
689 |
|
|
|
3,027 |
|
|
|
2,133 |
|
Integration and transaction expense |
|
184 |
|
|
|
196 |
|
|
|
2,184 |
|
|
|
2,073 |
|
Amortization of intangible assets |
|
988 |
|
|
|
761 |
|
|
|
2,793 |
|
|
|
2,353 |
|
Amortization of inventory step-up |
|
134 |
|
|
|
104 |
|
|
|
391 |
|
|
|
440 |
|
Other non-recurring charges (1) |
|
349 |
|
|
|
— |
|
|
|
1,057 |
|
|
|
— |
|
Income tax effect on adjustments |
|
(671 |
) |
|
|
(438 |
) |
|
|
(2,363 |
) |
|
|
(1,750 |
) |
Adjusted income from continuing operations |
$ |
3,179 |
|
|
$ |
968 |
|
|
$ |
3,972 |
|
|
$ |
2,685 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Adjusted EPS |
$ |
0.09 |
|
|
$ |
0.03 |
|
|
$ |
0.12 |
|
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted weighted average shares (in thousands): |
|
|
|
|
|
|
|
||||||||
Diluted |
|
34,105 |
|
|
|
33,781 |
|
|
|
32,492 |
|
|
|
33,586 |
|
(1) - Other non-recurring charges include severance, customer accommodation, facility consolidation and debt refinancing costs. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005999/en/
Investor Contact:
Phone: 540-769-8465
Email: IR@lunainc.com
Source:
FAQ
What were Luna Innovations' Q3 2022 earnings results?
How did Luna's Adjusted EBITDA perform in Q3 2022?
What is Luna Innovations' revenue outlook for 2022?
What are the key financial highlights for Luna Innovations in Q3 2022?